Genelux Corp. (GNLX)
Genelux Market Cap : 101.03M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 90.21M |
| November 16, 2026 | 86.60M |
| November 13, 2026 | 84.12M |
| November 12, 2026 | 85.70M |
| November 11, 2026 | 84.79M |
| November 10, 2026 | 87.95M |
| November 09, 2026 | 93.36M |
| November 06, 2026 | 88.40M |
| November 05, 2026 | 82.09M |
| November 04, 2026 | 88.40M |
| November 03, 2026 | 86.60M |
| November 02, 2026 | 90.21M |
| October 30, 2026 | 93.82M |
| October 29, 2026 | 94.72M |
| October 28, 2026 | 99.68M |
| October 27, 2026 | 92.46M |
| October 26, 2026 | 86.15M |
| October 23, 2026 | 90.21M |
| October 22, 2026 | 89.30M |
| October 21, 2026 | 93.36M |
| October 20, 2026 | 112.76M |
| October 19, 2026 | 110.50M |
| October 16, 2026 | 109.15M |
| October 15, 2026 | 111.86M |
| October 14, 2026 | 104.64M |
| Date | Value |
|---|---|
| October 13, 2026 | 113.66M |
| October 12, 2026 | 114.79M |
| October 09, 2026 | 115.46M |
| October 08, 2026 | 112.76M |
| October 07, 2026 | 113.66M |
| October 06, 2026 | 114.56M |
| October 05, 2026 | 117.27M |
| October 02, 2026 | 115.46M |
| October 01, 2026 | 113.66M |
| September 30, 2026 | 114.11M |
| September 29, 2026 | 110.50M |
| September 28, 2026 | 111.41M |
| September 25, 2026 | 111.86M |
| September 24, 2026 | 109.60M |
| September 23, 2026 | 113.44M |
| September 22, 2026 | 117.72M |
| September 21, 2026 | 115.46M |
| September 18, 2026 | 114.11M |
| September 17, 2026 | 114.11M |
| September 16, 2026 | 105.54M |
| September 15, 2026 | 111.41M |
| September 14, 2026 | 114.56M |
| September 11, 2026 | 112.31M |
| September 10, 2026 | 111.86M |
| September 09, 2026 | 113.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.082B |
| Alnylam Pharmaceuticals, Inc. | 20.01B |
| Anika Therapeutics, Inc. | 182.43M |
| Savara, Inc. | 973.21M |
| Arrowhead Pharmaceuticals, Inc. | 6.092B |
Market Cap Related Metrics
| PS Ratio | 12048.72 |
| PEG Ratio | -3.837 |
| Price to Book Value | 11.10 |
| Price | 2.24 |
| Earnings Yield | -39.51% |
| PEGY Ratio | -3.837 |